204 related articles for article (PubMed ID: 36420874)
1. Metabolomics of asthma, COPD, and asthma-COPD overlap: an overview.
Dasgupta S; Ghosh N; Bhattacharyya P; Roy Chowdhury S; Chaudhury K
Crit Rev Clin Lab Sci; 2023 Mar; 60(2):153-170. PubMed ID: 36420874
[TBL] [Abstract][Full Text] [Related]
2. Global metabolome profiling of exhaled breath condensates in male smokers with asthma COPD overlap and prediction of the disease.
Ghosh N; Choudhury P; Joshi M; Bhattacharyya P; Roychowdhury S; Banerjee R; Chaudhury K
Sci Rep; 2021 Aug; 11(1):16664. PubMed ID: 34404870
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic signatures of asthma-COPD overlap (ACO) are different from asthma and COPD.
Ghosh N; Choudhury P; Subramani E; Saha D; Sengupta S; Joshi M; Banerjee R; Roychowdhury S; Bhattacharyya P; Chaudhury K
Metabolomics; 2019 Jun; 15(6):87. PubMed ID: 31165288
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic fingerprinting and systemic inflammatory profiling of asthma COPD overlap (ACO).
Ghosh N; Choudhury P; Kaushik SR; Arya R; Nanda R; Bhattacharyya P; Roychowdhury S; Banerjee R; Chaudhury K
Respir Res; 2020 May; 21(1):126. PubMed ID: 32448302
[TBL] [Abstract][Full Text] [Related]
5. Eicosanoids metabolized through LOX distinguish asthma-COPD overlap from COPD by metabolomics study.
Cai C; Bian X; Xue M; Liu X; Hu H; Wang J; Zheng SG; Sun B; Wu JL
Int J Chron Obstruct Pulmon Dis; 2019; 14():1769-1778. PubMed ID: 31496676
[TBL] [Abstract][Full Text] [Related]
6. Quantitative determination of potential urine biomarkers of respiratory illnesses using new targeted metabolomic approach.
Khamis MM; Adamko DJ; Purves RW; El-Aneed A
Anal Chim Acta; 2019 Jan; 1047():81-92. PubMed ID: 30567667
[TBL] [Abstract][Full Text] [Related]
7. Redefining the overlap of asthma and COPD.
Drug Ther Bull; 2017 Jul; 55(7):66-69. PubMed ID: 28701317
[TBL] [Abstract][Full Text] [Related]
8. Identification of Asthma-COPD Overlap, Asthma, and Chronic Obstructive Pulmonary Disease Phenotypes in Patients with Airway Obstruction: Influence on Treatment Approach.
Romem A; Rokach A; Bohadana A; Babai P; Arish N; Azulai H; Glazer M; Izbicki G
Respiration; 2020; 99(1):35-42. PubMed ID: 31694032
[TBL] [Abstract][Full Text] [Related]
9. The metabolomics of airway diseases, including COPD, asthma and cystic fibrosis.
Nobakht M Gh BF; Aliannejad R; Rezaei-Tavirani M; Taheri S; Oskouie AA
Biomarkers; 2015 Feb; 20(1):5-16. PubMed ID: 25403491
[TBL] [Abstract][Full Text] [Related]
10. Investigating Fractional Exhaled Nitric Oxide in Chronic Obstructive Pulmonary Disease (COPD) and Asthma-COPD Overlap (ACO): A Scoping Review.
Mostafavi-Pour-Manshadi SM; Naderi N; Barrecheguren M; Dehghan A; Bourbeau J
COPD; 2018; 15(4):377-391. PubMed ID: 30067401
[TBL] [Abstract][Full Text] [Related]
11. Update on Asthma-COPD Overlap (ACO): A Narrative Review.
Mekov E; Nuñez A; Sin DD; Ichinose M; Rhee CK; Maselli DJ; Coté A; Suppli Ulrik C; Maltais F; Anzueto A; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2021; 16():1783-1799. PubMed ID: 34168440
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic Profiling Differences among Asthma, COPD, and Healthy Subjects: A LC-MS-based Metabolomic Analysis.
Liang Y; Gai XY; Chang C; Zhang X; Wang J; Li TT
Biomed Environ Sci; 2019 Sep; 32(9):659-672. PubMed ID: 31635682
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of asthma, COPD and asthma-COPD overlap among primary care physicians and respiratory/allergy specialists: A global survey.
Jenkins C; FitzGerald JM; Martinez FJ; Postma DS; Rennard S; van der Molen T; Gardev A; Genofre E; Calverley P
Clin Respir J; 2019 Jun; 13(6):355-367. PubMed ID: 30825365
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic profiling of asthma and chronic obstructive pulmonary disease: A pilot study differentiating diseases.
Adamko DJ; Nair P; Mayers I; Tsuyuki RT; Regush S; Rowe BH
J Allergy Clin Immunol; 2015 Sep; 136(3):571-580.e3. PubMed ID: 26152317
[TBL] [Abstract][Full Text] [Related]
15. An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD.
Correnti S; Preianò M; Gamboni F; Stephenson D; Pelaia C; Pelaia G; Savino R; D'Alessandro A; Terracciano R
J Transl Med; 2024 Mar; 22(1):301. PubMed ID: 38521955
[TBL] [Abstract][Full Text] [Related]
16. Functional Predictors Discriminating Asthma-COPD Overlap (ACO) from Chronic Obstructive Pulmonary Disease (COPD).
Kraemer R; Gardin F; Smith HJ; Baty F; Barandun J; Piecyk A; Minder S; Salomon J; Frey M; Brutsche MH; Matthys H
Int J Chron Obstruct Pulmon Dis; 2022; 17():2723-2743. PubMed ID: 36304971
[TBL] [Abstract][Full Text] [Related]
17. Increased urinary l-histidine in patients with asthma-COPD overlap: a pilot study.
Oh JY; Lee YS; Min KH; Hur GY; Lee SY; Kang KH; Rhee CK; Park SJ; Khan A; Na J; Park YH; Shim JJ
Int J Chron Obstruct Pulmon Dis; 2018; 13():1809-1818. PubMed ID: 29892192
[TBL] [Abstract][Full Text] [Related]
18. Definition and diagnosis of asthma-COPD overlap (ACO).
Yanagisawa S; Ichinose M
Allergol Int; 2018 Apr; 67(2):172-178. PubMed ID: 29433946
[TBL] [Abstract][Full Text] [Related]
19. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
